Published in J Neurol Neurosurg Psychiatry on July 01, 1996
Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc (2009) 1.88
Heterogeneity of Polyneuropathy Associated with Anti-MAG Antibodies. J Immunol Res (2015) 0.78
Entrapment in anti myelin-associated glycoprotein neuropathy. J Neurol (2009) 0.77
Comparison of monoclonal gammopathy of undetermined significance-associated neuropathy and chronic inflammatory demyelinating polyneuropathy patients. J Neurol (2014) 0.76
Immunotherapy in Peripheral Neuropathies. Neurotherapeutics (2016) 0.76
Long-Lasting Cranial Nerve III Palsy as a Presenting Feature of Chronic Inflammatory Demyelinating Polyneuropathy. Case Rep Med (2015) 0.75
Chronic inflammatory demyelinative polyneuropathy. J Neurol (2002) 0.75
Neuro-ophthalmological Complications of Chronic Inflammatory Demyelinating Polyradiculoneuropathy. Neuroophthalmology (2013) 0.75
A case of cauda equina syndrome in early-onset chronic inflammatory demyelinating polyneuropathy clinically similar to charcot-marie-tooth disease type 1. J Korean Neurosurg Soc (2014) 0.75
Is distal motor and/or sensory demyelination a distinctive feature of anti-MAG neuropathy? J Neurol (2016) 0.75
Chronic inflammatory polyradiculoneuropathy. Mayo Clin Proc (1975) 3.01
Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain (1987) 1.98
Chronic relapsing polyneuritis. J Neurol Sci (1976) 1.94
Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol (1989) 1.88
Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical, electrophysiological and magnetic resonance imaging study. J Neurol Neurosurg Psychiatry (1990) 1.87
Myelin-associated glycoprotein is the antigen for a monoclonal IgM in polyneuropathy. J Neurochem (1982) 1.75
The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies. Neurology (1982) 1.63
Subacute idiopathic demyelinating polyradiculoneuropathy. Arch Neurol (1992) 1.60
Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol (1981) 1.48
Combined central and peripheral myelinopathy. Neurology (1987) 1.40
Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology (1987) 1.36
Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain (1987) 1.27
Polyneuropathy and IgM monoclonal gammopathy: studies on the pathogenetic role of anti-myelin-associated glycoprotein antibody. Ann Neurol (1985) 1.20
Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve (1989) 1.18
Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain (1994) 1.12
Chronic inflammatory demyelinating polyneuropathy. Conduction failure before and during immunoglobulin or plasma therapy. Brain (1989) 1.11
Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy. Muscle Nerve (1991) 1.11
"Chronic sensory demyelinating neuropathy": chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy. J Neurol Neurosurg Psychiatry (1992) 1.11
Presentation and initial clinical course in patients with chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients without and with monoclonal gammopathy. Neurology (1993) 1.09
The electrodiagnostic findings in peripheral neuropathy associated with monoclonal gammopathy. Muscle Nerve (1983) 1.07
Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry (1995) 1.06
Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies. Ann Neurol (1995) 1.04
Peripheral neuropathies associated with monoclonal proteins: a clinical review. Muscle Nerve (1985) 1.03
The clinical spectrum of peripheral neuropathies associated with benign monoclonal IgM, IgG and IgA paraproteinaemia. Comparative clinical, immunological and nerve biopsy findings. J Neurol (1991) 1.02
Pathogenesis and therapy of neuropathies associated with monoclonal gammopathies. Ann Neurol (1995) 1.02
Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy. Ann Neurol (1994) 0.99
Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain (1995) 0.99
Central lesions in chronic inflammatory demyelinating polyneuropathy: an MRI study. Neurology (1990) 0.98
The electrodiagnostic findings in polyneuropathies associated with IgM monoclonal gammopathies. Muscle Nerve (1990) 0.96
The natural history of chronic demyelinating neuropathy associated with benign IgM paraproteinaemia. A clinical and neurophysiological study. Brain (1994) 0.94
Motor conduction parameters in neuropathies associated with anti-MAG antibodies and other types of demyelinating and axonal neuropathies. Muscle Nerve (1995) 0.92
Polyneuropathy associated with monoclonal gammopathy of undetermined significance: further evidence that IgM-MGUS neuropathies are different than IgG-MGUS. Neurology (1993) 0.90
Monoclonal gammopathy and neuropathy: myelin-associated glycoprotein reactivity and clinical characteristics. Neurology (1986) 0.89
A case of chronic sensory demyelinating neuropathy responding to immunotherapies. Muscle Nerve (1992) 0.89
Chronic inflammatory demyelinating polyradiculoneuropathy: comparison of patients with and without an associated monoclonal gammopathy. Neurology (1992) 0.86
Cranial magnetic resonance imaging in chronic demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry (1990) 0.84
Sensitivity and specificity of diagnostic criteria for conduction block in chronic inflammatory demyelinating polyneuropathy. Electroencephalogr Clin Neurophysiol (1993) 0.84
[Chronic polyradiculoneuritis. 25 cases]. Rev Neurol (Paris) (1992) 0.80
Late motor involvement in cases presenting as "chronic sensory demyelinating polyneuropathy". Muscle Nerve (1995) 0.79
AAEE case report #17: Peripheral neuropathy in monoclonal gammopathy of undetermined significance. Muscle Nerve (1989) 0.79
Chronic inflammatory demyelinating polyneuropathy. Semin Neurol (1993) 0.78
Inflammatory-demyelinating polyneuropathies. Neurol Clin (1992) 0.77
Chronic immune demyelinating neuropathies. Semin Neurol (1994) 0.77
Immune-mediated neuropathies. Curr Opin Neurol (1993) 0.77
[Peripheral neuropathies caused by perhexiline maleate. Apropos of 7 cases]. Coeur Med Interne (1977) 2.30
X-linked Charcot-Marie-Tooth disease with connexin 32 mutations: clinical and electrophysiologic study. Neurology (1998) 1.96
Phenotypic and genetic study of a family with hereditary sensory neuropathy and prominent weakness. Muscle Nerve (2000) 1.49
Missense CACNA1A mutation causing episodic ataxia type 2. Arch Neurol (2001) 1.44
Hereditary thermosensitive neuropathy: an autosomal dominant disorder of the peripheral nervous system. Neurology (1997) 1.42
[Cranial nerve injuries during multifocal neuropathies with persistent conduction blocks]. Rev Neurol (Paris) (1998) 1.39
Fine mapping of de novo CMT1A and HNPP rearrangements within CMT1A-REPs evidences two distinct sex-dependent mechanisms and candidate sequences involved in recombination. Hum Mol Genet (1998) 1.38
Spectrum of clinical and electrophysiologic features in HNPP patients with the 17p11.2 deletion. Neurology (1999) 1.38
Neurological complications of primary Sjögren's syndrome. J Neurol (2001) 1.34
Cervical magnetic stimulation: a new painless method for bilateral phrenic nerve stimulation in conscious humans. J Appl Physiol (1985) (1989) 1.27
MR Imaging of the cervical cord in juvenile amyotrophy of distal upper extremity. AJNR Am J Neuroradiol (1989) 1.24
Clinical, electrophysiologic, and molecular correlations in 13 families with hereditary neuropathy with liability to pressure palsies and a chromosome 17p11.2 deletion. Neurology (1995) 1.18
Sex-dependent rearrangements resulting in CMT1A and HNPP. Nat Genet (1997) 1.15
Collapsing cristobalitelike structures in silica analogues at high pressure. Phys Rev Lett (2003) 1.13
Guidelines for diagnosis of hereditary neuropathy with liability to pressure palsies. Neuromuscul Disord (2000) 1.13
Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome. Brain (2004) 1.12
Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study. J Neurol Neurosurg Psychiatry (2009) 1.10
Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study. Brain (2001) 1.09
Plasma exchange and chlorambucil in polyneuropathy associated with monoclonal IgM gammopathy. IgM-associated Polyneuropathy Study Group. J Neurol Neurosurg Psychiatry (1995) 1.08
Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study. Neurology (2009) 1.06
Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry (1995) 1.06
European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Eur J Neurol (2006) 1.04
Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinaemia. Ann Rheum Dis (2001) 1.04
Peripheral neuropathy associated with IgM monoclonal gammopathy: correlations between M-protein antibody activity and clinical/electrophysiological features in 40 cases. Muscle Nerve (1998) 1.03
[Letter: 7 peripheral neuropathies after treatment by perhexiline maleate]. Nouv Presse Med (1976) 1.03
Clinical, electrophysiological and molecular genetic characteristics of 93 patients with X-linked Charcot-Marie-Tooth disease. Brain (2001) 1.02
Neuropathy in lymphoma: a relationship between the pattern of neuropathy, type of lymphoma and prognosis? J Neurol Neurosurg Psychiatry (2007) 1.01
The spectrum of polyneuropathies in patients infected with HIV. J Neurol Neurosurg Psychiatry (1989) 0.98
[Study of antiglycolipid antibodies in IgM monoclonal dysglobulinemias associated with peripheral neuropathy]. Rev Neurol (Paris) (1988) 0.98
A de novo case of hereditary neuropathy with liability to pressure palsies (HNPP) of maternal origin: a new mechanism for deletion in 17p11.2? Hum Mol Genet (1996) 0.97
Miller Fisher syndrome: clinical and electrophysiologic evidence of peripheral origin in 10 cases. Neurology (1984) 0.96
Emotion recognition impairment and apathy after subthalamic nucleus stimulation in Parkinson's disease have separate neural substrates. Neuropsychologia (2008) 0.96
Duplication within chromosome 17p11.2 in 12 families of French ancestry with Charcot-Marie-Tooth disease type 1a. The French CMT Research Group. J Med Genet (1992) 0.95
The frequency of 17p11.2 duplication and Connexin 32 mutations in 282 Charcot-Marie-Tooth families in relation to the mode of inheritance and motor nerve conduction velocity. Neuromuscul Disord (2001) 0.95
Double-blind study of the efficacy and safety of milnacipran and imipramine in elderly patients with major depressive episode. Acta Psychiatr Scand (1998) 0.94
Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients. J Neurol Neurosurg Psychiatry (2008) 0.93
Subthalamic nucleus stimulation affects orbitofrontal cortex in facial emotion recognition: a PET study. Brain (2008) 0.93
Polyneuropathy associated with IgG/IgA monoclonal gammopathy: a clinical and electrophysiological study of 15 cases. Eur J Neurol (2003) 0.92
Clinical and electrophysiological study of the peripheral nervous system in the elderly. J Neurol (1993) 0.92
Chorea and polycythaemia. J Neurol (1985) 0.92
Effects of transcranial magnetic stimulation over the region of the supplementary motor area during sequences of memory-guided saccades. Exp Brain Res (1995) 0.92
Crystalline post-quartz phase in silica at high pressure. Phys Rev Lett (2001) 0.91
Systemic lupus erythematosus with anti-Hu antibodies and polyradiculoneuropathy. Neurology (2001) 0.90
The spectrum of changes on 20 nerve biopsies in patients with HIV infection. Muscle Nerve (1989) 0.90
Detection of deletion within 17p11.2 in 7 French families with hereditary neuropathy with liability to pressure palsies (HNPP). Cytogenet Cell Genet (1994) 0.89
Peripheral neuropathy in systemic vasculitis: clinical and electrophysiologic study of 22 patients. Neurology (1986) 0.89
[Spasm or dimpling of the hypothenar eminence]. Rev Neurol (Paris) (1985) 0.89
Peripheral neuropathy associated with essential mixed cryoglobulinaemia: a role for hepatitis C virus infection? J Neurol Neurosurg Psychiatry (1996) 0.89
Charcot-Marie-Tooth disease with intermediate motor nerve conduction velocities: characterization of 14 Cx32 mutations in 35 families. Hum Mutat (1997) 0.89
Primary lateral sclerosis: further clarification. J Neurol Sci (2001) 0.89
[Development and contribution to the validation of a brief French version of the Yesavage Geriatric Depression Scale]. Encephale (1997) 0.89
Ganglioside GD1b is the target antigen for a biclonal IgM in a case of sensory-motor axonal polyneuropathy: involvement of N-acetylneuraminic acid in the epitope. Ann Neurol (1992) 0.89
Association between centromeric deletions of the SMN gene and sporadic adult-onset lower motor neuron disease. Ann Neurol (1998) 0.88
Hereditary neuralgic amyotrophy and hereditary neuropathy with liability to pressure palsies: two distinct clinical, electrophysiologic, and genetic entities. Neurology (1994) 0.87
Perhexiline maleate and peripheral neuropathy. Neurology (1979) 0.87
[Communicating hydrocephalus disclosing neurosyphilis]. Rev Neurol (Paris) (1990) 0.86
Family, Alzheimer's disease and negative symptoms. Int J Geriatr Psychiatry (2001) 0.85
Delayed response tasks in basal ganglia lesions in man: further evidence for a striato-frontal cooperation in behavioural adaptation. Neuropsychologia (1996) 0.85
[Acute polyarthritis disclosing an esophageal carcinoma. Apropos of 2 cases]. Rev Rhum Mal Osteoartic (1981) 0.84
Non-anti-MAG DADS neuropathy as a variant of CIDP: clinical, electrophysiological, laboratory features and response to treatment in 10 cases. Eur J Neurol (2010) 0.83
[Peripheral neuropathies due to perhexiline maleate (author's transl)]. Ann Cardiol Angeiol (Paris) (1977) 0.83
True neurogenic thoracic outlet syndrome: electrophysiological diagnosis in six cases. Muscle Nerve (1998) 0.83
Recurrent polyradiculoneuropathy with the 17p11.2 deletion. Muscle Nerve (1997) 0.83
[Progressive muscular atrophy localized in the hand. Monomelic form of motor neuron disease?]. Rev Neurol (Paris) (1988) 0.83
[Treatment of immune deficient neuropathies with intravenous polyvalent immunoglobulins. An open study of 16 cases]. Rev Neurol (Paris) (1993) 0.83
Human immunoglobulin treatment of multifocal motor neuropathy and polyneuropathy associated with monoclonal gammopathy. J Neurol Neurosurg Psychiatry (1994) 0.83
Quantitative analysis of monoclonal immunoglobulins in serum of patients with amyotrophic lateral sclerosis. J Neurol Sci (1991) 0.83
Lymphoma-induced polyradiculopathy in AIDS: two cases. J Neurol (1992) 0.82
Focal glomerulosclerosis associated with Charcot-Marie-Tooth disease. Nephron (1985) 0.82
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, genetic homogeneity, and mapping of the locus within a 2-cM interval. Am J Hum Genet (1996) 0.82
Constant rearrangement of the CMT1A-REP sequences in HNPP patients with a deletion in chromosome 17p11.2: a study of 30 unrelated cases. The French CMT Collaborative Research Group. Hum Mol Genet (1995) 0.82
Antiganglioside antibodies in motor-neuron diseases and peripheral neuropathies: study by ELISA technique and immunodetection on thin-layer chromatography. Neurochem Int (1992) 0.81
Interferon beta-1a as an investigational treatment for CIDP. Neurology (2003) 0.81
151st ENMC international workshop: Inflammatory Neuropathy Consortium 13th-15th April 2007, Schiphol, The Netherlands. Neuromuscul Disord (2007) 0.81